Prevention and treatment of the cognitive disorders of late age by use of the polyunsaturated fatty acids: current state and perspectives
Abstract
The article discusses the possibility of using of polyunsaturated fatty acids for prevention and treatment of cognitive disorders in old age. Current state and prospects of using of the eicosapentaenoic acid and the docosahexaenoic acid for this purpose are analyzed. Considering a demographic trends in developed countries in recent decades, the growing proportion of the elderly and the accompanying increase of frequency of the neurodegenerative diseases, it seems appropriate the prophylactic administration of a polyunsaturated fatty acids. It is clear that the prevalence of atherosclerosis-related disease (coronary heart disease, myocardial infarction) and its risk factors (arterial hypertension, obesity, diabetes mellitus, hyperhomocysteinemia) vary in different populations and lower in Mediterranean regions due to nutrition peculiarities such as consumption of polyunsaturated fatty acids. In addition, it is shown that the risk factors for Alzheimer’s disease and atherosclerosis-related diseases are similar.
About the Author
A. V. Sukhanov
RAMS
Russian Federation
Russian Federation
SB RAMS
Establishment of the Russian Academy of Medical Sciences Research Institute of Therapy
630089
st. Boris Bogatkov, 175/1
Novosibirsk
References
1. Чернявская Т. К. Пожилой ученик в Школе больных артериальной гипертонией. Неврологические причины невыученных уроков / Т. К. Чернявская // Приложение Consilium medicum: неврология/ревматология. – 2011. – № 2. – С. 22–26.
2. Суханов А. В. Молекулярно-генетические факторы риска болезни Альцгеймера / А. В. Суханов [и др.] // Журн. неврологии и психиатрии им. Корсакова. – 2001. – Т. 91, № 1. – С. 65–68.
3. Суханов А. В. Современные подходы к диагностике деменции / А. В. Суханов, В. Л. Фейгин, Ц. П. Короленко // Сибирский вестник психиатрии и наркологии. – 2000. – Т. 10, № 4. – С. 8–13.
4. Suhanov A. V., Pilipenko P. I., Korczyn A. D., Hofman A., Voevoda M. I., Shishkin S. V., Simonova G. I., Nikitin Y. P., Feigin V. L. Risk factors for Alzheimer’s disease in Russia: a case-control study // Eur. J. Neurol. 2006. Vol. 13, N 9. P. 990–995.
5. World Health Organization Neurological Disorders: Public Health Challenges – Switzerland: World Health Organization, 2006. P. 204–207.
6. Ferri C. P., Prince M., Brayne C. et al. Global prevalence of dementia: a Delphi consensus study // Lancet. 2005. Vol. 366, N 9503. P. 2112–2117.
7. Valcour V. G., Masaki K. H., Curb J. D. et al. The detection of dementia in the primary care setting // Arch. Intern. Med. 2000. Vol. 160. P. 2964–2968.
8. Whitney E., Rolfes S. R. Understanding Nutrition 11th Ed. California: Thomson Wadsworth, 2008. P. 154.
9. Brenna J. T. Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man // Curr. Opin. Clin. Nutr. Metab. Care. 2002. Vol. 5, N 2. P. 127–132.
10. Gerster H. Can adults adequately convert alpha-linolenic acid (18:3n-3) to eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3)? // Int. J. Vitam. Nutr. Res. 1998. Vol. 68, N 3. P. 159–173.
11. Burdge G. C., Calder P. C. Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults // Reprod. Nutr. Dev. 2005. Vol. 45, N 5. P. 581–597.
12. Holman R. T. The slow discovery of the importance of omega 3 essential fatty acids in human health // J. Nutr. 1998. Vol. 128 (2 Suppl.). P. 427S–433S.
13. Innis S. M. Dietary (n-3) fatty acids and brain development // J. Nutr. 2007. Vol. 137, N 4. P. 855–859.
14. Bourre J. M. [Omega-3 fatty acids in psychiatry] // Med. Sci. (Paris). 2005. Vol. 21, N 2. P. 216–221.
15. Chang Chia-Yu, Ke Der-Shin, Chen Jen-Yin. Essential fatty acids and human brain // Acta Neurol. Taiwan. 2009. Vol. 18, N 4. P. 231–241.
16. Bourre J. M. Where to find omega-3 fatty acids and how feeding animals with diet enriched in omega-3 fatty acids to increase nutritional value of derived products for human: what is actually useful? // J. Nutr. Health Aging. 2005. Vol. 9, N 4. P. 232–242.
17. Терешина Е. В. Роль жирных кислот в развитии возрастного окислительного стресса. Гипотеза / Е. В. Терешина // Успехи геронтол. – 2007. – Т. 20, № 1. – С. 59–65.
18. Гуляева Н. В. Роль свободнорадикальных процессов в развитии нейродегенеративных заболеваний (болезнь Паркинсона и болезнь Альцгеймера) / Н. В. Гуляева, А. Н. Ерин // Нейрохимия. – 1995. – Т. 12, № 3. – С. 3–15.
19. Зозуля Ю. А.. Свободнорадикальное окисление и антиоксидантная защита при патологии головного мозга / Ю. А. Зозуля, В. А. Барабой, Д. А. Сутковой. – М.: Знание-М, 2000. – 344 с.
20. Хавинсон В. Х. Свободнорадикальное окисление и старение / В. Х. Хавинсон [и др.]. – СПб.: Наука, 2003. – 327 с.
21. Harman D. Aging: A theory based on free radical and radiation chemistry // J. Gerontol. 1956. Vol. 11. P. 298–300.
22. Анисимов В. Н. Влияние мелатонина и эпиталамина на активность антиоксидантной системы у крыс / В. Н. Анисимов, А. В. Арутюнян, В. Х. Хавинсон // Докл. РАН. – 1997. – Т. 352. – С. 831–833.
23. Обухова Л. К. Роль свободно-радикальных реакций окисления в молекулярных механизмах старения живых организмов / Л. К. Обухова, И. М. Эмануэль // Успехи химии. – 1983. – Т. 52. – С. 353–372.
24. Дубинина Е. Е. Показатели окислительного стресса при нейродегенеративных заболеваниях (сосудистая деменция, болезнь Альцгеймера) / Е. Е. Дубинина, С. В. Ковругина, П. В. Коновалов // Успехи геронтол. – 2007. – Т. 20, № 4. – С. 109–113.
25. Riediger N. D., Othman R. A., Suh M. et al. A systemic review of the roles of n-3 fatty acids in health and disease // J. Am. Diet. Assoc. 2009. Vol. 109, N 4. P. 668–679.
26. Pawlosky R. J., Hibbeln J. R., Novotny J. A. et al. Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans // J. Lipid. Res. 2001. Vol. 42, N 8. P. 1257–1265.
27. Gamoh S., Hashimoto M., Hossain S., Masumura S. Chronic administration of docosahexaenoic acid improves the performance of radial arm maze task in aged rats // Clin. Exp. Pharmacol. Physiol. 2001. Vol. 28. N 4. P. 266–270.
28. Lim S. Y., Suzuki H. Intakes of dietary docosahexaenoic acid ethyl ester and egg phosphatidylcholine improve maze-learning ability in young and old mice // J. Nutr. 2000. Vol. 130, N 6. P. 1629–1632.
29. Calon F., Lim G. P., Yang F. et al. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer’s disease mouse model // Neuron. 2004. Vol. 43, N 5. P. 633–645.
30. Hashimoto M., Hossain S., Shimada T. et al. Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer’s disease model rats // J. Neurochem. 2002. Vol. 81, N 5. P. 1084–1091.
31. Lukiw W. J., Cui J. G., Marcheselli V. L. et al. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease // J. Clin. Invest. 2005. Vol. 115, N 10. P. 2774–2783.
32. Tully A. M., Roche H. M., Doyle R. et al. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer’s disease: a case-control study // Br. J. Nutr. 2003. Vol. 89, N 4. P. 483—489.
33. Cole G. M., Ma Qiu-Lan, Frautschy S.A. Omega-3 fatty acids and dementia // Prostaglandins Leukot. Essent. Fatty Acids. 2009. Vol. 81, N 2-3. P. 213–221.
34. Robinson J. G., Ijioma N., Harris W. Omega-3 fatty acids and cognitive function in women // Womens Health (Lond. Engl). 2010. Vol. 6, N 1. P. 119–134.
35. Li D., Hu X. Fish and its multiple human health effects in times of threat to sustainability and affordability: are there alternatives? // Asia Pac. J. Clin. Nutr. 2009. Vol. 18, N 4. P. 553–563.
36. Albanese E., Dangour A. D., Uauy R. A. et al. Dietary fish and meat intake and dementia in Latin America, China, and India: a 10/66 Dementia Research Group population-based study // Am. J. Clin. Nutr. 2009. Vol. 90, N 2. P. 392–400.
37. Barberger-Gateau P., Raffaitin C., Letenneur L. et al. Dietary patterns and risk of dementia: the Three-City cohort study // Neurology. 2007. Vol. 69, N 20. P. 1921–1930.
38. Panza F., Solfrizzi V., Colacicco A. M. et al. Mediterranean diet and cognitive decline // Public Health Nutr. 2004. Vol. 7, N 7. P. 959–963.
39. Cherubini A., Andres-Lacueva C., Martin A. et al. Low plasma N-3 fatty acids and dementia in older persons: the InCHIANTI study // J. Gerontol. A Biol. Sci. Med. Sci. 2007. Vol. 62, N 10. P. 1120–1126.
40. Freund-Levi Y., Eriksdotter-Jonhagen M., Cederholm T. et al. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial // Arch. Neurol. 2006. Vol. 63, N 10. P. 1402–1408.
41. Drevon C. A. N-6 and n-3 fatty acids - how much and which balance? // Scand. J. Nutr. 1990. Vol. 34. P. 56–61.
42. Симонова Г. И. Питание и атеросклероз / Г. И. Симонова; под ред. Ю. П. Никитина // Вопросы атерогенеза. – Новосибирск, 2005. – С. 350–361.
Review
For citations:
Sukhanov A.V. Prevention and treatment of the cognitive disorders of late age by use of the polyunsaturated fatty acids: current state and perspectives. Ateroscleroz. 2012;8(1):54-60. (In Russ.)
Views:
137
Email this article 